Drug development in metastatic prostate cancer: lessons from ACIS

Lancet Oncol. 2021 Nov;22(11):1487-1488. doi: 10.1016/S1470-2045(21)00458-7. Epub 2021 Sep 30.

Authors

Umang Swami¹, Neeraj Agarwal²

Affiliations

¹ Huntsman Cancer Institute, University of Utah (NCI-CCC), Salt Lake City, UT 84112, USA.
² Huntsman Cancer Institute, University of Utah (NCI-CCC), Salt Lake City, UT 84112, USA. Electronic address: neeraj.agarwal@hci.utah.edu.

PMID: 34600603
DOI: 10.1016/S1470-2045(21)00458-7

No abstract available

Publication types

Comment

MeSH terms

Drug Development
Humans
Male
Prostatic Neoplasms* / drug therapy
Uterine Cervical Neoplasms*